realtalkms.com/447 🧬 NG01, a remyelinating cell therapy, just received an FDA designation designed to speed its development.
It’s one more step toward therapies that may repair damage in MS. Get all the details on RealTalk MS. ��
#MultipleSclerosis #RealTalkMS #MSResearch
MSToronto2026: Abstracts, Registration & Housing Now Open!
Share your research, connect with MS leaders, and join sessions on breakthroughs in care & treatment.
🔗 Submit, register & book:mstoronto2026.orgn
#MSToronto2026 #MSResearch #MultipleSclerosisi